ArticleJournal of cancer research and clinical oncology2023

A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials.

Anna Fleischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.